Role of nitric oxide in the renal protective effects of ischemic preconditioning

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 3, 2003, Pages 419-427

  Yamashita, Junji ^a   Ogata, Masaya ^a   Itoh, Makoto ^a   Yamasowa, Hiroshi ^a   Shimeda, Yuka ^a   Takaoka, Masanori ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Acute renal failure; Endothelial NO synthase; Endothelin 1; Ischemic preconditioning; Nitric oxide

Indexed keywords

AMINOGUANIDINE; ENDOTHELIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE ABSORPTION; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOOD UREA NITROGEN; ENDOTHELIN-1; ENZYME INHIBITORS; GUANIDINES; ISCHEMIC PRECONDITIONING; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0041336962     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200309000-00014     Document Type: Article

References (40)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia. A delay of lethal cellular injury in ischemic myocardium. Circulation. 1986; 74:1124-1136.
2. Li GC, Vasquez JA, Gallagher KP, et al. Myocardial protection with preconditioning. Circulation. 1990;82:609-619.
3. + channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A. 1995;92:4666-4670.
4. 2 receptors. Hepatology. 1999;29:126-132.
5. Lee HT, Schroeder CA, Shah P, et al. Preconditioning with ischemia or adenosine protects skeletal muscle from ischemic tissue reperfusion injury. J Surg Res. 1996;63:29-34.
6. 3 receptors. Am J Physiol. 2000;278:F380-F387.
7. i/o proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection. J Am Soc Nephrol. 2001;12:233-240.
8. Pagliano P, Gattullo D, Rastaldo R, et al. Ischemic preconditioning: From the first to the second window of protection. Life Sci. 2001;69:1-15.
9. 1 receptor, KATP channels, and ischemic preconditioning in dogs. Am J Physiol. 1993;264:H1321-H1336.
10. Bolli R, Bhatti ZA, Tang XL, et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:42-52.
11. Takano H, Manchikalapudi S, Tang XL, et al. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation. 1998;98:441-449.
12. Ruilope LM, Lahera V, Rodicio JL, et al. Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens. 1994;12:625-631.
13. Shultz PJ, Tayeh MA, Marletta MA, et al. Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am J Physiol. 1991;261: F600-F606.
14. Mundel P, Bachmann S, Bader M, et al. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int. 1992;42:1017-1019.
15. Terada Y, Tomita K, Nonoguchi H, et al. Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest. 1992;90:659-665.
16. Yu L, Gengaro PE, Niederberger M, et al. Nitric oxide: A mediator in rat tubular hypoxia/reoxigenation injury. Proc Natl Acad Sci U S A. 1994;91: 1691-1695.
17. Chintala MS, Chiu PJS, Vemulapalli S, et al. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn-Schmiedeberg's Arch Pharmacol. 1993;348: 305-310.
18. Matsumura Y, Nishiura M, Deguchi S, et al. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats. J Pharmacol Exp Ther. 1998;287:1084-1091.
19. Takaoka M, Kuro T, Matsumura Y, et al. Role of endothelin in the pathogenesis of acute renal failure. Drug News & Perspective. 2000;13: 141-146.
20. Toda N, Kitamura Y, Okamura T. Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension. 1993;21:3-8.
21. Ortiz MC, Fortepiani LA, Martinez C, et al. Renal and pressor effects of aminoguanidine in cirrhotic rats with ascites. J Am Soc Nephrol. 1996;7: 2694-2699.
22. 2+ exchange inhibitor, KB-R7943, shows renal protective effects in rats with ischemic acute renal failure. J Pharmacol Exp Ther. 2000;296:412-419.
23. Solez K, Kramer EC, Fox JA, et al. Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure. Kidney Int. 1974;6: 24-37.
24. Yamada K, Nabeshima T. Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats. J Neurochem. 1997;68:1234-1243.
25. A receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br J Pharmacol. 1995;114:925-930.
26. Matsumura Y, Ikegawa R, Takaoka M, et al. Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cells. Biochem Biophys Res Commun. 1990;167:203-210.
27. Cochrane J, Williams BT, Benerjee A, et al. Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Ren Fail. 1999;21:135-145.
28. Ogawa T, Nussler AK, Tuzuner E, et al. Contribution of nitric oxide to the protective effects if ischemic preconditioning in ischemia-reperfused rat kidney. J Lab Clin Med. 2001;138:50-58.
29. Torras J, Herrero-Fresneda I, Lloberas N, et al. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int. 2002;61: 2218-2227.
30. Lochner A, Marais E, Genade S, et al. Nitric oxide: a trigger for classic preconditioning? Am J Physiol. 2000;279:H2752-H2765.
31. Ping P, Takano H, Zhang J, et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits. A signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res. 1999;84:587-604.
32. Sasaki N, Sato T, Ohler A, et al. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation. 2000;101: 439-445.
33. Peralta C, Closa D, Hotter G, et al. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun. 1996;229:264-270.
34. Shibouta Y, Suzuki N, Shino A, et al. Pathophysiological role of endothelin in acute renal failure. Life Sci. 1990;46:1611-1618.
35. Firth JD, Ratcliffe PJ. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest. 1992;90:1023-1031.
36. Matsumura Y, Kuro T, Kobayashi Y, et al. Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats. Jpn J Pharmacol. 2000;84:16-24.
37. Gellai M, Jugus M, Fletcher T, et al. Non peptide endothelin receptor antagonists V. Prevention and reversal of acute renal failure in the rat by SB 209670. J Pharmacol Exp Ther. 1995;275:200-206.
38. B receptor is protective against ischemic acute renal failure in rats. Jpn J Pharmacol. 2000;82:307-316.
39. Boulanger C, Lüscher TF. Release of endothelin from porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;85: 587-590.
40. Mitsutomi N, Akashi C, Odagiri J, et al. Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. Eur J Pharmacol. 1999;364:65-73.